Trials / Unknown
UnknownNCT01022723
Clinical Validation of a Microfluidic Device for Isolation and Molecular Characterization of Circulating Tumor Cells
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 817 (estimated)
- Sponsor
- National Cancer Centre, Singapore · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
To evaluate the efficiency of a microdevice for circulating tumor cells isolation and to correlate the circulating titre with response and progression.
Detailed description
* Validate the clinical use of a mircofluidic device to capture circulating timor cells from a broad range of tumor types * Characterize and identify these circulating tumor cells and demostrate cell viability with this capture method * Apply this technology in clinically relevant settings and correlate to response to treatment and disease progression * Elucidate predictive and pharmacodynamic biomarkers in the context of early phase trials of novel therapeutics
Conditions
Timeline
- Start date
- 2009-10-01
- Primary completion
- 2018-12-01
- Completion
- 2018-12-01
- First posted
- 2009-12-01
- Last updated
- 2018-09-14
Locations
1 site across 1 country: Singapore
Source: ClinicalTrials.gov record NCT01022723. Inclusion in this directory is not an endorsement.